CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

AKTXAkari Therapeutics Plc

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $8.84 · 2026-10-01
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
CountryUSA
RECENT INSIDER TRADES
  • 2026-10-01 · Gaslightwala Abizer (CEO) · OTHER
  • 2026-08-19 · Farag Kameel D. (Interim CFO) · OTHER
  • 2026-07-17 · Patel Samir Rashmikant (Director) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders10
Shares held170,555
Value$1.40M
Percent of shares outstanding0.00%
As of quarter end2026-06-30
RECENT NEWS
  • Akari Therapeutics files patent for cancer payload technology
  • Akari Therapeutics files PCT patent for ADC payload targeting RNA splicing in cancers
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Akari Therapeutics Plc (AKTX) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit